A randomized controlled trial comparing intermittent with continuous dialysis in patients with ARF

Machine translation Machine translation
类别 Primary study
期刊AMERICAN JOURNAL OF KIDNEY DISEASES
Year 2004
背景:尽管连​​续肾脏替代治疗在危重病人急性肾功能衰竭(ARF)的广泛使用,有几个数据,比传统的间歇性血液透析(IHD)的支持它的好处。我们试图分析与IHD相比连续性静脉 - 静脉血液透析(CVVHD)生存在研究方式之间的差异。CVVHD或缺血性心脏病的治疗疾病的严重程度后分层随机方法:85与急性肾功能衰竭需要透析的危重病人。结果:有生存或群体之间的肾功能恢复无显着差异。在死亡的病人,平均存活时间为10.7 + / - IHD组为11.2天与14.3 + / - 16.1天CVVHD组(P值不显着)。有更大CVVHD集团的净容积在去除72小时。在72小时尿量下降两组间相似。平均动脉压和关闭透析治疗进行回顾性分析。有一个CVVHD治疗缺血性心脏病治疗的患者平均动脉压显着下降,但是这并没有导致生存优势。结论:尽管更大的音量控制,CVVHD并没有导致到一个在的生存的的改善,保存作者:的尿液输出,或肾功能复苏与IHD相比,在与ARF的的患者。
Epistemonikos ID: de366c109685a79b3b7689bfb0f9bc18aff22588
First added on: Sep 23, 2011
Warning
This is a machine translation from an article in Epistemonikos.

Machine translations cannot be considered reliable in order to make health decisions.

See an official translation in the following languages: English

If you prefer to see the machine translation we assume you accept our terms of use